IOBC.F Stock Overview
Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 5/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 1/6 |
Ion Beam Applications SA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €13.50 |
52 Week High | €18.00 |
52 Week Low | €8.65 |
Beta | 0.84 |
1 Month Change | 30.43% |
3 Month Change | 10.66% |
1 Year Change | -16.92% |
3 Year Change | -23.77% |
5 Year Change | -18.67% |
Change since IPO | 158.62% |
Recent News & Updates
Recent updates
Shareholder Returns
IOBC.F | US Medical Equipment | US Market | |
---|---|---|---|
7D | 8.0% | -0.2% | 0.6% |
1Y | -16.9% | 12.0% | 29.5% |
Return vs Industry: IOBC.F underperformed the US Medical Equipment industry which returned 12% over the past year.
Return vs Market: IOBC.F underperformed the US Market which returned 29.5% over the past year.
Price Volatility
IOBC.F volatility | |
---|---|
IOBC.F Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 7.8% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.9% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: IOBC.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine IOBC.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1986 | 2,000 | Olivier Legrain | https://www.iba-worldwide.com |
Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems.
Ion Beam Applications SA Fundamentals Summary
IOBC.F fundamental statistics | |
---|---|
Market cap | US$414.12m |
Earnings (TTM) | -US$9.86m |
Revenue (TTM) | US$463.88m |
0.8x
P/S Ratio-38.4x
P/E RatioIs IOBC.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
IOBC.F income statement (TTM) | |
---|---|
Revenue | €428.72m |
Cost of Revenue | €0 |
Gross Profit | €428.72m |
Other Expenses | €437.83m |
Earnings | -€9.11m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 23, 2024
Earnings per share (EPS) | -0.31 |
Gross Margin | 100.00% |
Net Profit Margin | -2.12% |
Debt/Equity Ratio | 47.9% |
How did IOBC.F perform over the long term?
See historical performance and comparison